CLRB SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0001172661-26-003421
CLRB filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. A Schedule 13G was filed regarding Cellectar Biosciences, Inc. (CLRB), indicating a passive ownership position by a reporting holder. The stock moved +4.8% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Cellectar Biosciences, Inc. (CLRB), indicating a passive ownership position by a reporting holder. The filing directory does not disclose the holder's identity, ownership percentage, or share count.
Key details
How CLRB stock reacted
Close before
$2.48
Aug 13, 2026
First close after
+4.84%
$2.60
5 trading days
+4.44%
$2.59
Since filing
-49.60%
$1.25
✦ Ask GOAX AI about this filing — what it means for CLRB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLRB?
Click hereFrequently asked questions
What did CLRB file with the SEC on Aug 14, 2026?
CLRB filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Cellectar Biosciences, Inc. (CLRB), indicating a passive ownership position by a reporting holder. The filing directory does not disclose the holder's identity, ownership percentage, or share count.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did CLRB stock react to this filing?
CLRB closed at $2.48 before the filing and $2.60 on Aug 14, 2026 (+4.84%). Five trading days later: $2.59 (+4.44%).
Other CLRB SEC filings
Get alerts when CLRB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days